Brain cancers represent one of the most aggressive tumors that are especially challenging to treat through drugs, partially due to the inherent protection by the blood-brain barrier. Therefore, developing drugs that have specific chemical properties that allow them to cross the blood-brain-barrier, while simultaneously retaining their drug-like features is a heavily sought-after approach in treating […]
Read More